RE: Piled into GCAT: low AISC, production up, royalty financing more than mcap + JV coming. Soon 2 producing projects. £100mil mcap target11 Aug 2023 18:32
BJ,
"As Rob mentioned they have options and they can choose from between them. Anything beyond this statement is speculation that we should avoid."
No, avoid any comment which isn't in an RNS. "Rob" has a lot of previous form for saying things in interviews which do not transpire. He's also partial for not declaring CLNS(A.k.a death spiral finance) when they are taken out, but declares them months later when it's likely that those CLN's are being drawn down and the poor PI isn't aware why there is so much selling.
Having said that, RNS' from this company have always brought up more questions than they answer. The latest update another example.
You obviously wasn't invested last year, when "Rob" said funding was secured from OCIM in an RNS on 21/12/2002, yet that wasn't true.
RNS Quote : "With funding secured from OCIM and Philoro, Caracal is fully funded to deliver the Kilimapesa expansion project and exploration programmes in both Kenya and Tanzania."
It's probably worth your time going back through all the Proactive and Stock box interviews over the last couple of years, then seeing if what was said came to fruition.
The 1-2-1 Frankfurt interview is also worth watching from last year, where he also mentioned it was secured.
Corporate governance IMO is the responsibility of the man at the top, yet all we've seen is resignations. Only the Chairman and CEO left, with one NED that's linked to Orca and Thomas Koenig.
This isn't a strong buy imo, not until the prospectus is issue with all the shares owed to Orca £2m and £2m to Koenig last year, then another $1m to Orca this year. Then the 150m owed to mayflower, as per RTO prospectus. 117M owing to Tyacks for the Tanz acquisition(RNS 12th Aug 2022). 37.5m to previous directors pre RTO(3rd Aug 2022). Then a proportion of the 152m Mgt incentives(see RTO prospectus) which would have been met their criteria.
DYOR and GLA